Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer

Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer

IntroductionPatients with advanced germ cell tumors (GCT) receiving cisplatin-based chemotherapy have high rates of thromboembolic events (TEE) which can negatively affect their overall survival. While primary TEE prophylaxis during chemotherapy may prevent these events, it is unclear which patients...

Full description

Bibliographic Details
Main Authors: Xiaosong Meng, Murtaza Ahmed, Kevin D. Courtney, Waddah Arafat, Ibrahim Ibrahim, Vitaly Margulis, Craig Nichols, Aditya Bagrodia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
germ cell tumor
thromboembolic event
chemotherapy
anticoagulation
cisplatin
khorana risk score
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.724682/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.724682/full

Similar Items